Generex Announces Collaboration with Merck to Evaluate KEYTRUDA (pembrolizumab)
Generex Biotechnology Corporation announced that its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com) has entered into a clinical trial collaboration agreement…
Read More...
Read More...